Factor Bioscience
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1035 Cambridge St Ste 17B, Cambridge, Ma...Phone Number
(781) 640-1031Website
factor.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Factor Bioscience
Factor Bioscience specializes in cell engineering technologies aimed at treating diseases and enhancing health. The company focuses on innovations in mRNA, gene editing, cell reprogramming, and nucleic acid delivery to develop advanced cell therapies. With over a decade of experience and a robust patent portfolio, Factor collaborates with strategic partners to accelerate the development of transformative medicines. Their target clients include patients in need of innovative therapies, particularly in the fields of cancer treatment and genetic diseases.Explore more
Factor Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Factor Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Factor Bioscience launches new products
Earning: See what the market has to say on Factor Bioscience recently announced quarterly report
Check out if Factor Bioscience is spiking on competitors!
Factor Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Factor Bioscience has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Factor Bioscience
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Factor Bioscience had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Factor Bioscience has new funding data
Recommended Actions
Find VP level buyers at Factor Bioscience
Find more new buyers
Compare Similar Companies to Factor Bioscience
Compare insights from companies similar to Factor Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Factor Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Factor Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Factor Bioscience.
Factor Bioscience Tech Stack
A closer look at the technologies used by Factor Bioscience
Most Recent Scoops
Project
Spending/Investment
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Project
Intellectual Property, Legal Affairs
Partnership
Project
Partnership, Product Management, Intellectual Property, Bioengineering, Medical Research, Healthcare Technology
Factor Bioscience News & Media
Factor Bioscience to Showcase Engineered iMacrophages (FACT-112) Targeting Ovarian Cancer In Vivo at ISCT 2026
- Factor to reveal latest pre-clinical data on FACT-112: engineered iMacrophages for treating solid-tumors CAMBRIDGE, Mass., April 30, 2026 /PRNewswire/ -- Factor Bioscience Inc., a Cambridge-based biotechnology company focused on using its pioneering gene-editing platform to develop...Factor Bioscience Files Complaint Against Cellectis and AstraZeneca Alleging Infringement of Foundational Gene-Editing Patents
Alleges infringement of three U.S. gene-editing patents Infringed patents support multiple product pipelines, including Factor's allogeneic cancer cell therapy programs Cites need to take action to protect Factor's ability to bring innovative cancer treatments to patients CAMBRIDGE,...Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases
CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) and Factor Bioscience Limited (“Factor”) today announced an exclusive license and collaboration agreement aimed at accelerating the development of advanced cell therapy candidates for oncology, rare diseases, and autoimmune disorders. Under the terms of the agreement, Eterna has secured a worldwide, exclusive, non-transferable, royalty-bearing license, with the right to grant sFactor Bioscience to Deliver Six Presentations at the International Society for Stem Cell Research (ISSCR) 2024 Annual Meeting
Factor to reveal engineered iPSC-derived macrophages that enhance T cell cytotoxicity to triple negative breast and ovarian cancer cells Presentations will include latest preclinical data from Factor's stealth iPSC and nucleic acid delivery platforms CAMBRIDGE, Mass., July 9, 2024...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Factor Bioscience
Sign Up For FreeTo access detailed company insights
Factor Bioscience specializes in cell engineering technologies aimed at treating diseases and enhancing health. The company focuses on innovations in mRNA, gene editing, cell reprogramming, and nucleic acid delivery to develop advanced cell therapies. With over a decade of experience and a robust patent portfolio, Factor collaborates with strategic... Read More
